Yatharth Hospital Grants 2.5 Lakh Stock Options Under ESOP Scheme 2024
Yatharth Hospital & Trauma Care Services Limited has granted 250,000 stock options under its ESOP Scheme 2024. The exercise price is ₹10 per option. Vesting begins one year from the grant date and can extend up to four years. Options can be exercised within two years post-vesting.
ESOP grants are standard practice for employee incentives and typically have a minimal immediate impact on the company's stock price or overall valuation.
The announcement is a routine ESOP grant and does not contain any significant positive or negative financial or business developments.
Yatharth Hospital & Trauma Care Services Limited announced today, August 10, 2026, that its Nomination and Remuneration Committee (NRC) has approved the grant of 250,000 stock options under the "Yatharth Hospital & Trauma Care Services Employee Stock Option Scheme – 2024". The NRC meeting, held on August 10, 2026, commenced at 11:15 AM IST and concluded at 11:50 AM IST.
The approved grant includes 250,000 options, each convertible into one equity share of face value ₹10. The exercise price for these options has been set at ₹10 per option, equivalent to the face value of the company's shares. The scheme is in compliance with SEBI (Share Based Employee Benefits and Share Buyback) Regulations, 2021.
Vesting of the options will commence one year from the grant date and can extend up to a maximum of four years, at the discretion of the committee. After vesting, employees can exercise their options within a maximum period of two years. In the event of death or permanent disability of a grantee, the minimum vesting period will not apply. The company expects that 250,000 equity shares of face value ₹10 each will arise if all granted options are vested and exercised. This information is also available on the company's website.
What to do with a filing like this
Yatharth Hospital & Trauma Care Services Limited filed this with the NSE as a statutory disclosure, categorised under designated person disclosures. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Yatharth Hospital & Trauma Care Services Limited. Read the original for the full detail.